Skip to content
healthcare.dev

LACOSAMIDE

NDC 50228-192, LACOSAMIDE, tablet, film coated, from ScieGen Pharmaceuticals Inc.

Product NDC
50228-192
Status
Listed
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205237
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-192 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE50 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
50228-192-10502280192101000 TABLET, FILM COATED in 1 BOTTLE (50228-192-10)
50228-192-305022801923030 TABLET, FILM COATED in 1 BOTTLE (50228-192-30)
50228-192-605022801926060 TABLET, FILM COATED in 1 BOTTLE (50228-192-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f4ffa3ad-1278-4772-9ef8-ed6fdaa47605
  • NADAC price for package 50228019260

    GET /v1/drugs/nadac/50228019260

Use it

Look up 50228-192 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-192 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-192. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.